Skip to content

Total debt at other companies

Revvity logo
RevvityRVTY
$3.94B+17.8%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$445.39M+32.2%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
Guardant Health logo
Guardant HealthGH
Labcorp Holdings logo
Labcorp HoldingsLH

Other financials

Income statement

See full
Revenue$377.3M+1.2%
Gross profit$230.9M-2.9%
Operating income$81.3M-20.3%
Net income$118.4M+62.3%
EPS (diluted)$1.80+76.5%

Balance sheet

See full
Cash & equivalents$500.3M-46.8%
Total equity$1.2B+4.1%
Total assets$2.3B+14.2%

Cash flow

See full
Operating cash flow$125.1M+16.3%
CapEx$3.2M-63.0%
Free cash flow$121.9M+23.3%

Valuation

See full
Market cap$6.76B-26.3%
Enterprise value$6.89B-20.5%
P/E24.2×-10.2×
P/S4.4×-1.6×

Profitability

See full
Gross margin60.5%-3.6pp
Operating margin18.8%-10.7pp
Net margin18%+0.7pp
FCF margin24.4%-6.4pp

Returns & leverage

See full
Return on equity23.5%-1.7pp
Debt / equity0.5×0.0×
Current ratio2.8×-2.9×

Where this comes from

Calculated from Lantheus Holdings’s reported figures.

Plus components not separately reported this period.

The official record: Lantheus Holdings’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lantheus Holdings's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lantheus Holdings's total debt?
Lantheus Holdings (LNTH) reported total debt of $627.9M in Q1 2026.
How has Lantheus Holdings's total debt changed year-over-year?
Lantheus Holdings's total debt increased by 1.8% year-over-year, from $616.5M to $627.9M.
What is the long-term trend for Lantheus Holdings's total debt?
Over 5 years (2020 to 2025), Lantheus Holdings's total debt has grown at a 21.4% compound annual growth rate (CAGR), from $237.56M to $625.22M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.